These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7840594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cloning and nucleotide sequence of the DNA gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates.
    Kim JH, Cho EH, Kim KS, Kim HY, Kim YM.
    Antimicrob Agents Chemother; 1998 Jan; 42(1):190-3. PubMed ID: 9449286
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME.
    Am J Med; 1989 Nov 30; 87(5A):2S-8S. PubMed ID: 2574005
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance.
    Reyna F, Huesca M, González V, Fuchs LY.
    Antimicrob Agents Chemother; 1995 Jul 30; 39(7):1621-3. PubMed ID: 7492118
    [Abstract] [Full Text] [Related]

  • 9. Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis.
    Li Z, Deguchi T, Yasuda M, Kawamura T, Kanematsu E, Nishino Y, Ishihara S, Kawada Y.
    Antimicrob Agents Chemother; 1998 Dec 30; 42(12):3293-5. PubMed ID: 9835531
    [Abstract] [Full Text] [Related]

  • 10. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis.
    Zirnstein G, Li Y, Swaminathan B, Angulo F.
    J Clin Microbiol; 1999 Oct 30; 37(10):3276-80. PubMed ID: 10488192
    [Abstract] [Full Text] [Related]

  • 11. Analysis of the NH2-terminal 83rd amino acid of Escherichia coli GyrA in quinolone-resistance.
    Yonezawa M, Takahata M, Banzawa N, Matsubara N, Watanabe Y, Narita H.
    Microbiol Immunol; 1995 Oct 30; 39(4):243-7. PubMed ID: 7651238
    [Abstract] [Full Text] [Related]

  • 12. Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India.
    Brown JC, Shanahan PM, Jesudason MV, Thomson CJ, Amyes SG.
    J Antimicrob Chemother; 1996 May 30; 37(5):891-900. PubMed ID: 8737139
    [Abstract] [Full Text] [Related]

  • 13. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.
    Ruiz J, Marco F, Goñi P, Gallardo F, Mensa J, Trilla A, Jimenez de Anta T, Vila J.
    J Antimicrob Chemother; 1995 Oct 30; 36(4):737-8. PubMed ID: 8591951
    [No Abstract] [Full Text] [Related]

  • 14. DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa.
    Yonezawa M, Takahata M, Matsubara N, Watanabe Y, Narita H.
    Antimicrob Agents Chemother; 1995 Sep 30; 39(9):1970-2. PubMed ID: 8540700
    [Abstract] [Full Text] [Related]

  • 15. Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrA gene from strain PAO1 and quinolone-resistant clinical isolates.
    Kureishi A, Diver JM, Beckthold B, Schollaardt T, Bryan LE.
    Antimicrob Agents Chemother; 1994 Sep 30; 38(9):1944-52. PubMed ID: 7811002
    [Abstract] [Full Text] [Related]

  • 16. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S, Hooper DC, Tankovic J, Soussy CJ.
    Antimicrob Agents Chemother; 1995 Aug 30; 39(8):1667-70. PubMed ID: 7486897
    [Abstract] [Full Text] [Related]

  • 17. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom.
    Piddock LJ, Ricci V, McLaren I, Griggs DJ.
    J Antimicrob Chemother; 1998 Jun 30; 41(6):635-41. PubMed ID: 9687102
    [Abstract] [Full Text] [Related]

  • 18. Type II topoisomerase quinolone resistance-determining regions of Aeromonas caviae, A. hydrophila, and A. sobria complexes and mutations associated with quinolone resistance.
    Goñi-Urriza M, Arpin C, Capdepuy M, Dubois V, Caumette P, Quentin C.
    Antimicrob Agents Chemother; 2002 Feb 30; 46(2):350-9. PubMed ID: 11796341
    [Abstract] [Full Text] [Related]

  • 19. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC.
    Gibreel A, Sjögren E, Kaijser B, Wretlind B, Sköld O.
    Antimicrob Agents Chemother; 1998 Dec 30; 42(12):3276-8. PubMed ID: 9835526
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the mechanisms of quinolone resistance in clinical isolates of Citrobacter freundii.
    Navia MM, Ruiz J, Ribera A, de Anta MT, Vila J.
    J Antimicrob Chemother; 1999 Dec 30; 44(6):743-8. PubMed ID: 10590274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.